TRAVERE THERAPEUTICS INC - NOTE 2.500% 9/1

Q3 2025 13F Holders as of 30 Sep 2025

Type / Class
Debt / NOTE 2.500% 9/1
Total 13F principal
$0
Principal change
-$57,640,000
Total reported market value
$0
Number of holders
0
Value change
-$64,873,603
Number of sells
8

There are no holders of TRAVERE THERAPEUTICS INC - NOTE 2.500% 9/1 as of Q3 2025.